The Radiopharmaceutical Theranostics CDMO Market is becoming an increasingly important part of the global precision oncology and nuclear medicine ecosystem as radioligand therapies, targeted alpha therapies, companion diagnostics, and personalized treatment approaches progress through clinical development and commercialization. Radiopharmaceutical contract development and manufacturing...